ELAVL1 and central nervous system cancer: Increased TSPO in glioma cells may attract HUR to shuttle from the nucleus to the cytoplasm, promoting HUR binding and increasing the mRNA stability of MAPKAPK3, thus activating the oncoprotein CREB and promoting glioma cell proliferation and mobility.